The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...
A paper published in the Journal of Clinical Oncology, titled "Comparative Analysis of Intracranial Response Assessment ...
The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for ...
Chess is an immersive 1v1 board game that requires high strategies and patience. The rules of chess may seem simple, but it requires deep thinking. Each player has sixteen pieces. These pieces are ...
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis ...
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.
The FDA has approved subcutaneous nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) to treat a range of solid tumor malignancies.
Facing a public relations checkmate, the International Chess Federation surrendered and allowed world champ Magnus Carlsen to ...
Irvine is a moderate Republican, a retired army general and former commander of the 96th Infantry of the U.S. Army Reserve at Fort Douglas. He served four terms in the House, from 1972 to 1980. “The ...
Chess champion Magnus Carlsen pulled off a sartorial checkmate after returning to a recent tournament despite wearing jeans, ...
Among the most profound results presented at the 2024 European Society for Medical Oncology Congress were the 10-year data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback